Y. Miyakawa

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Y Miyakawa, Y. Miyakawa, Yuzo Miyakawa
Publication record
299 papers · 23,120 citations · H-index 77

PAPERS

Hepatitis B virus strains of subgenotype A 2 with an identical sequence spreading rapidly from the capital region to all over Japan in patients with acute hepatitis
20177 citationsauthor #12
Estimated numbers of patients with liver disease related to hepatitis B or C virus infection based on the database reconstructed from medical claims from 2008 to 2010 in Japan
201516 citationsauthor #10
Seroprevalence, genotypic distribution and potential risk factors of hepatitis B and C virus infections among adults in Siem Reap, Cambodia
201542 citationsauthor #12
Hepatitis B virus infection in hemodialysis patients in Japan: Prevalence, incidence and occult hepatitis B virus infection
201514 citationsauthor #12
High prevalences of hepatitis B and C virus infections among adults living in Binh Thuan province, Vietnam
201534 citationsauthor #9
Validation and limitation of age–period–cohort model in simulating mortality due to hepatocellular carcinoma from 1940 to 2010 in Japan
201412 citationsauthor #5
Seroclearance rate of hepatitis B surface antigen in 2,112 patients with chronic hepatitis in Japan during long-term follow-up
201443 citationsauthor #12
Estimating numbers of persons with persistent hepatitis B virus infection transmitted vertically and horizontally in the birth cohort during 1950–1985 in Japan
201414 citationsauthor #7
High levels of hepatitis B virus after the onset of disease lead to chronic infection in patients with acute hepatitis B.
201320 citationsauthor #10
Follow up of the 987 blood donors found with hepatitis C virus infection over 9–18 years
20128 citationsauthor #10
Prediction of early HBeAg seroconversion by decreased titers of HBeAg in the serum combined with increased grades of lobular inflammation in the liver
201217 citationsauthor #12
Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virus
201239 citationsauthor #13
Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b.
2012113 citationsauthor #15
Total Numbers of Undiagnosed Carriers of Hepatitis C and B Viruses in Japan Estimated by Age- and Area-Specific Prevalence on the National Scale
2011147 citationsauthor #9
Influence of ITPA polymorphisms on decreases of hemoglobin during treatment with pegylated interferon, ribavirin, and telaprevir
2011101 citationsauthor #16
Hepatitis B virus strains of subgenotype A2 with an identical sequence spreading rapidly from the capital region to all over Japan in patients with acute hepatitis B
201133 citationsauthor #18
Interferon Alone or Combined with Ribavirin for Acute Prolonged Infection with Hepatitis C Virus in Chimpanzees
20110 citationsauthor #6
Development of HCC in patients receiving adefovir dipivoxil for lamivudine‐resistant hepatitis B virus mutants
201023 citationsauthor #13
Association of HLA-DR14 with the Treatment Response in Japanese Patients with Autoimmune Hepatitis
201010 citationsauthor #14
Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus
201082 citationsauthor #14
Influence of amino‐acid polymorphism in the core protein on progression of liver disease in patients infected with hepatitis C virus genotype 1b
201028 citationsauthor #13
Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C
200950 citationsauthor #9
A Genetic Variant of Hepatitis B Virus Divergent from Known Human and Ape Genotypes Isolated from a Japanese Patient and Provisionally Assigned to New Genotype J
2009452 citationsauthor #9
Efficacy of entecavir treatment for lamivudine‐resistant hepatitis B over 3 years: Histological improvement or entecavir resistance?
200923 citationsauthor #13
An Open Pilot Study Exploring the Efficacy of Fluvastatin, Pegylated Interferon and Ribavirin in Patients with Hepatitis C Virus Genotype 1b in High Viral Loads
200988 citationsauthor #10
Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP‐424), pegylated interferon and ribavirin for 12 weeks
200927 citationsauthor #15
Case–control study for the identification of virological factors associated with fulminant hepatitis B
200938 citationsauthor #22
Development of hepatocellular carcinoma in elderly patients with chronic hepatitis C with or without elevated aspartate and alanine aminotransferase levels
20096 citationsauthor #15
Poor Response to Pegylated Interferon and Ribavirin in Older Women Infected with Hepatitis C Virus of Genotype 1b in High Viral Loads
200991 citationsauthor #12
Distribution of Hepatitis B Virus Genotypes among Patients with Chronic Infection in Japan Shifting toward an Increase of Genotype A
2009131 citationsauthor #21
Virulent Strain of Hepatitis E Virus Genotype 3, Japan
200960 citationsauthor #11
Change of hepatitis B virus genotypes in acute and chronic infections in Japan
200842 citationsauthor #14
Detection of HBV core promoter and precore mutations helps distinguish flares of chronic hepatitis from acute hepatitis B
200814 citationsauthor #13
ISOLATION OF DANE PARTICLES CONTAINING A DNA STRAND BY M ETR IZA M I D E DENS I TY GRADIENT
20080 citationsauthor #4
Titration of hepatitis B virus infectivity in the sera of pre‐acute and late acute phases of HBV infection: Transmission experiments to chimeric mice with human liver repopulated hepatocytes
200853 citationsauthor #8
Incidence Rates of Hepatitis B and C Virus Infections among Blood Donors in Hiroshima, Japan, during 10 Years from 1994 to 2004
200831 citationsauthor #7
Liver disease in hepatitis C virus carriers identified at blood donation and their outcomes with or without interferon treatment: Study on 1019 carriers followed for 5–10 years
200713 citationsauthor #24
Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C
200789 citationsauthor #7
Prediction of Response to Pegylated Interferon and Ribavirin in Hepatitis C by Polymorphisms in the Viral Core Protein and Very Early Dynamics of Viremia
200757 citationsauthor #12
Loss of hepatitis B surface antigen from the serum of patients with chronic hepatitis treated with lamivudine
200720 citationsauthor #13
Early dynamics of hepatitis B virus in chimeric mice carrying human hepatocytes monoinfected or coinfected with genotype G
200743 citationsauthor #10
Age-specific Antibody to Hepatitis E Virus Stays Constant during the Past 20 Years in Japan Short title : Silent HEV infection in Japan
20070 citationsauthor #7
Influence of hepatitis B virus genotypes on the intra‐ and extracellular expression of viral DNA and antigens
2006287 citationsauthor #12
Immunoprophylaxis of perinatal infection with hepatitis B virus on the national scale.
20063 citationsauthor #1
Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan.
200670 citationsauthor #27
Virological outcomes in patients infected chronically with hepatitis B virus genotype A in comparison with genotypes B and C
200618 citationsauthor #13
Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection
2006228 citationsauthor #21
Response to long‐term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C
200628 citationsauthor #13
Natural history of compensated cirrhosis in the Child‐Pugh class a compared between 490 patients with hepatitis C and 167 with B virus infections
200661 citationsauthor #11
Molecular evolutionary analyses implicate injection treatment for schistosomiasis in the initial hepatitis C epidemics in Japan.
200553 citationsauthor #9
Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan
2005127 citationsauthor #14
Early Dynamics of Hepatitis C Virus in the Circulation of Chimpanzees with Experimental Infection
200511 citationsauthor #9
Spread Times of Hepatitis C Virus Estimated by the Molecular Clock Differ among Japan, the United States and Egypt in Reflection of Their Distinct Socioeconomic Backgrounds
200531 citationsauthor #3
Virological differences between patients infected with subtypes Ba and Bj of hepatitis B virus genotype B
200512 citationsauthor #14
National Prevention of Hepatocellular Carcinoma in Japan Based on Epidemiology of Hepatitis C Virus Infection in the General Population
200563 citationsauthor #3
Distinct geographic distributions of hepatitis B virus genotypes in patients with acute infection in Japan
200564 citationsauthor #13
Classifying genotype F of hepatitis B virus into F1 and F2 subtypes.
200533 citationsauthor #11
Chronic Hepatitis C in Asia: Epidemiology, Pathophysiology, Hepatocellular Carcinoma and Treatment: 2nd MMRF Meeting on Viral Hepatitis in Asia, Tokyo, May 2004: Proceedings
20050 citationsauthor #2
Hepatitis C virus infection in 2,744 hemodialysis patients followed regularly at nine centers in Hiroshima during November 1999 through February 2003
200529 citationsauthor #7
Two subtypes of genotype B (Ba and Bj) of hepatitis B virus in Japan.
200486 citationsauthor #13
Peripheral CD8+/CD25+ lymphocytes may be implicated in hepatocellular injuries in patients with acute-onset autoimmune hepatitis
200412 citationsauthor #14
Wild‐type precore and core promoter sequences in patients with acute self‐limited or chronic hepatitis B
200423 citationsauthor #14
Exponential Spread of Hepatitis C Virus Genotype 4a in Egypt
200491 citationsauthor #9
Clinical and pathological characteristics of the autoimmune hepatitis and primary biliary cirrhosis overlap syndrome
200441 citationsauthor #10
Sex- and Age-Specific Carriers of Hepatitis B and C Viruses in Japan Estimated by the Prevalence in the 3,485,648 First-Time Blood Donors during 1995–2000
2004174 citationsauthor #8
A case‐control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D
2004163 citationsauthor #13
YMDD mutants in patients with chronic hepatitis B before treatment are not selected by lamivudine
200434 citationsauthor #14
Titration of Hepatitis C Virus in Chimpanzees for Determining the Copy Number Required for Transmission
200446 citationsauthor #10
Eight genotypes (A–H) of hepatitis B virus infecting patients from San Francisco and their demographic, clinical, and virological characteristics
200472 citationsauthor #11
Epidemiological and sequence differences between two subtypes (Ae and Aa) of hepatitis B virus genotype A.
2004160 citationsauthor #12
Epidemiological and clinical diffeences between hepatitis B virus genotype B with and without recombination with genotype C
20030 citationsauthor #13
Genotyping Hepatitis Virus: New Developments and Clinical Impact: 1st MMRF Meeting on Viral Hepatitis in Asia, Tokyo, January 2003: Proceedings
20030 citationsauthor #2
Classifying Hepatitis B Virus Genotypes
2003301 citationsauthor #1
Precore Wild-Type Hepatitis B Virus with G1896 in the Resolution of Persistent Hepatitis B Virus Infection
200312 citationsauthor #15
Natural histories of hepatitis C virus infection in men and women simulated by the Markov model
200341 citationsauthor #10
Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C.
2003217 citationsauthor #12
A case‐control study for early prediction of hepatitis B e antigen seroconversion by hepatitis B virus DNA levels and mutations in the precore region and core promoter
200334 citationsauthor #7
Contents Vol. 46, 2003
20030 citationsauthor #24
Interferon-alpha for reinfection with hepatitis C virus in two patients with chronic hepatitis C who had responded to previous therapies.
20030 citationsauthor #10
642 Outbreak of hepatitis C virus infection through contaminated fibrinogen concentrates in Japan-tracing the source by molecular evolutionary analysis
20030 citationsauthor #7
Histological Improvements after a Three-Year Lamivudine Therapy in Patients with Chronic Hepatitis B in Whom YMDD Mutants Did Not or Did Develop
200325 citationsauthor #10
Full-Length Sequences of Six Hepatitis E Virus Isolates of Genotypes III and IV from Patients with Sporadic Acute or Fulminant Hepatitis in Japan
200377 citationsauthor #6
Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease
2003111 citationsauthor #9
Subject Index Vol. 46, 2003
20030 citationsauthor #24
Lack of Epidemiological Evidence for a Role of Resolved Hepatitis B Virus Infection in Hepatocarcinogenesis in Patients Infected with Hepatitis C Virus in Japan
200313 citationsauthor #10
Symptomatic therapies for prevention of hepatocellular carcinoma developing in chronic hepatitis C
20030 citationsauthor #2
Frequent coinfection with hepatitis B virus strains of distinct genotypes detected by hybridization with type-specific probes immobilized on a solid-phase support.
200353 citationsauthor #15
CASE REPORT: Interferon-α for Reinfection with Hepatitis C Virus in Two Patients with Chronic Hepatitis C Who Had Responded to Previous Therapies
20031 citationsauthor #10
Characteristics of Hepatitis B Virus Isolates of Genotype G and Their Phylogenetic Differences from the Other Six Genotypes (A through F)
2002131 citationsauthor #7
GENETIC VARIABILITY IN HEPATITIAIS B VIRUSES
20022 citationsauthor #2
Hepatitis B Virus of Genotype B with or without Recombination with Genotype C over the Precore Region plus the Core Gene
2002302 citationsauthor #11
Interferon for treatment of breakthrough infection with hepatitis B virus mutants developing during long-term lamivudine therapy
200230 citationsauthor #10
Demographic, clinical, and virological characteristics of hepatocellular carcinoma in Asia: Survey of 414 patients from four countries
200234 citationsauthor #10
Genetic variability in hepatitis B viruses.
2002343 citationsauthor #2
Viral genotypes and response to interferon in patients with acute prolonged hepatitis B virus infection of adulthood in Japan
200267 citationsauthor #14
Hepatitis B e antigen in sera from individuals infected with hepatitis B virus of genotype G
200295 citationsauthor #9
Determination of hepatitis B virus genotype G by polymerase chain reaction with hemi-nested primers.
200189 citationsauthor #7
Toward prevention of hepatocellular carcinoma developing in chronic hepatitis C
20017 citationsauthor #1
Increasing incidence of hepatocellular carcinoma associated with hepatitis C virus infection in Japan.
20011 citationsauthor #1
A NOVEL DNA VIRUS (TTV) ASSOCIATED TRANSAMINASE LEVEL IN POSTTRANSFUSION HEPATITIS OF UNKOWN ETIOLOGY
20014 citationsauthor #4

TIMELINE

1966 18 citations

1967 24 citations

1968 1 citations

1969 64 citations

1970 16 citations

1971 35 citations

1973 0 citations

1974 93 citations

1975 305 citations

1976 961 citations

1977 133 citations

1978 98 citations

1979 648 citations

1980 259 citations

1981 427 citations

1982 279 citations

1983 508 citations

1984 67 citations

1985 161 citations

1986 541 citations

1987 269 citations

1988 1,131 citations

1989 78 citations

1990 1,780 citations

1991 397 citations

1992 1,664 citations

1993 174 citations

1994 1,726 citations

1995 369 citations

1996 865 citations

1997 1,619 citations

1998 1,114 citations

1999 785 citations

2000 358 citations

2001 101 citations

2002 1,004 citations

2003 885 citations

2004 902 citations

2005 423 citations

2006 695 citations

2007 222 citations

2008 140 citations

2009 966 citations

2010 143 citations

2011 281 citations

2012 177 citations

2013 20 citations

2014 69 citations

2015 106 citations

2017 7 citations

Unknown 16 citations

Y. Miyakawa

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT